Literature DB >> 16008828

Hyperphosphorylated tau and amyloid precursor protein deposition is increased in the brains of young drug abusers.

S N Ramage1, I C Anthony, F W Carnie, A Busuttil, R Robertson, J E Bell.   

Abstract

Drug abuse is a major problem worldwide. The incidence of drug-related deaths attributed to opiate abuse is increasing annually. Apart from routine examination, little is known of the neuropathology of drug abuse. We, and others, have shown previously that drug abuse is associated with microglial activation. We hypothesised that neuroinflammation might lead to premature neurodegeneration in drug abusers. We investigated the brains of young opiate abusers (n=34, all<40 years) for the presence of proteins associated with neurodegenerative diseases and compared them with the brains of age-matched, non-drug users (n=16) all of whom died suddenly. Detailed immunohistochemical analysis of the hippocampus, brainstem and basal ganglia for hyperphosphorylated tau, beta-amyloid, beta-amyloid precursor protein (betaAPP) and ubiquitin demonstrated an excess of AT 8-positive neurofibrillary tangles (NFT) in the drug abusers. These were not only more prevalent in the drug abusers than in controls (44%vs. 19%) but also involved more brain areas. In controls NFT were confined to the entorhinal cortex whereas in drug users they were also found in the subiculum, temporal neocortex, nucleus basalis of Meynert and the locus coeruleus. Virtually no amyloid plaques were present but betaAPP positivity was again much more common in drug abusers than controls (73%vs. 20% in the brainstem and 59%vs. 23% in the temporal lobe). There is no suggestion that these drug abusers had displayed major cognitive impairment although detailed neuropsychological assessment is difficult in this subject group. Likely causes of hyperphosphorylated tau deposition in drug abuse include hypoxic-ischaemic injury, microglial-associated cytokine release and possibly drug-associated neurotoxicity or hepatitis. Head injury, which is another major risk factor, does not appear to have contributed to our findings. Genetic factors also merit consideration. It is unclear at present how much of the hyperphosphorylated tau detected in these young drug abusers represents a transitory phenomenon.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008828     DOI: 10.1111/j.1365-2990.2005.00670.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  26 in total

Review 1.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 2.  Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia.

Authors:  Romain Barus; Johana Béné; Julie Deguil; Sophie Gautier; Régis Bordet
Journal:  Br J Pharmacol       Date:  2019-03-31       Impact factor: 8.739

Review 3.  HIV, opiates, and enteric neuron dysfunction.

Authors:  J J Galligan
Journal:  Neurogastroenterol Motil       Date:  2015-04       Impact factor: 3.598

4.  Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals.

Authors:  Seth M Dever; Blair N Costin; Ruqiang Xu; Nazira El-Hage; Joyce Balinang; Alexander Samoshkin; Megan A O'Brien; Marypeace McRae; Luda Diatchenko; Pamela E Knapp; Kurt F Hauser
Journal:  AIDS       Date:  2014-01-02       Impact factor: 4.177

5.  Prescription Opioids and Risk of Dementia or Cognitive Decline: A Prospective Cohort Study.

Authors:  Sascha Dublin; Rod L Walker; Shelly L Gray; Rebecca A Hubbard; Melissa L Anderson; Onchee Yu; Paul K Crane; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2015-08       Impact factor: 5.562

6.  Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusions.

Authors:  Gabor G Kovacs; Monika Cs Horvath; Katalin Majtenyi; Mirjam I Lutz; Yasmin L Hurd; Eva Keller
Journal:  Neurobiol Aging       Date:  2015-07-17       Impact factor: 4.673

7.  Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users.

Authors:  Donald B Smith; Peter Simmonds; Jeanne E Bell
Journal:  J Neurovirol       Date:  2014-01-14       Impact factor: 2.643

Review 8.  Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

9.  Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection.

Authors:  Negar Khanlou; David J Moore; Gursharan Chana; Mariana Cherner; Deborah Lazzaretto; Sharron Dawes; Igor Grant; Eliezer Masliah; Ian P Everall
Journal:  J Neurovirol       Date:  2009-04       Impact factor: 2.643

Review 10.  Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.

Authors:  Jeanne E Bell; Juan-Carlos Arango; Iain C Anthony
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.